英偉達 黃仁勳:與歐盟合作建20座新人工智能工廠
英偉達(NVDA.US)首席執行官黃仁勳周三表示,歐盟規劃與其公司合作建立20座新人工智能工廠,其中數座將是超級工廠,而英偉達將協助歐洲明年的AI計算能力提升十倍。
黃仁勳在巴黎的VivaTech大會上表示,英偉達正在七個歐洲國家建立人工智能技術中心,旨在與初創企業進行協作研究並建立人工智能生態系統。他宣布,英偉達將與法國公司Mistral合作建立一個人工智能雲,以提供他們的模型以及其他人工智能初創企業的應用程序。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.